| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.96B | 22.33B | 20.47B | 17.66B | 14.94B | 12.09B |
| Gross Profit | 5.99B | 4.67B | 4.29B | 5.20B | 4.76B | 3.86B |
| EBITDA | 2.06B | 1.10B | 566.58M | 1.93B | 2.24B | 1.61B |
| Net Income | 978.37M | 349.82M | 126.52M | 1.01B | 1.40B | 896.36M |
Balance Sheet | ||||||
| Total Assets | 11.61B | 11.87B | 11.68B | 11.37B | 10.44B | 8.68B |
| Cash, Cash Equivalents and Short-Term Investments | 3.52B | 4.01B | 3.78B | 4.48B | 5.23B | 4.14B |
| Total Debt | 605.32M | 939.75M | 715.83M | 662.78M | 598.25M | 392.10M |
| Total Liabilities | 5.70B | 6.07B | 5.75B | 5.01B | 4.54B | 4.06B |
| Stockholders Equity | 5.91B | 5.81B | 5.93B | 6.37B | 5.90B | 4.61B |
Cash Flow | ||||||
| Free Cash Flow | 1.33B | 1.15B | 561.30M | 1.26B | 1.64B | 1.78B |
| Operating Cash Flow | 1.36B | 1.21B | 584.97M | 1.40B | 1.65B | 1.83B |
| Investing Cash Flow | -46.86M | -49.66M | -100.03M | -1.17B | -98.81M | -57.80M |
| Financing Cash Flow | -970.19M | -923.62M | -1.19B | -980.29M | -468.95M | -751.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥12.51B | 11.62 | ― | 1.27% | 7.24% | 215.65% | |
71 Outperform | ¥19.79B | 16.52 | ― | 9.87% | 11.51% | -29.82% | |
69 Neutral | ¥14.32B | 12.09 | ― | 2.51% | 10.17% | 327.27% | |
66 Neutral | ¥8.38B | 12.89 | ― | 2.61% | 11.84% | 246.10% | |
66 Neutral | ¥19.48B | 8.10 | ― | 2.01% | 15.43% | 12.47% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥14.96B | 29.59 | ― | 7.85% | -3.20% | 34.08% |